NCT00979875View on ClinicalTrials.gov

A Pharmacokinetic and Glucodynamic Study of Subcutaneously Administered Insulin Analogs With rHuPH20 Compared to Insulin Analogs Alone

PHASE1CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

September 30, 2009

Primary Completion Date

February 28, 2010

Study Completion Date

May 31, 2010

Conditions
Healthy
Interventions
DRUG

Recombinant human hyaluronidase PH20 (rHuPH20)

DRUG

Insulin lispro

DRUG

Insulin glulisine

DRUG

Insulin aspart

Trial Locations (1)

91911

Profil Institute for Clinical Research, Inc., Chula Vista

Sponsors
All Listed Sponsors
lead

Halozyme Therapeutics

INDUSTRY